Evaluating imaging biomarkers for neurodegeneration in pre-symptomatic Huntington's disease using machine learning techniques

[1]  Bernhard Schölkopf,et al.  A tutorial on support vector regression , 2004, Stat. Comput..

[2]  M. Gluck,et al.  Human midbrain sensitivity to cognitive feedback and uncertainty during classification learning. , 2004, Journal of neurophysiology.

[3]  David S Tuch,et al.  Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures , 2006, Movement disorders : official journal of the Movement Disorder Society.

[4]  Stefan Klöppel,et al.  White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease. , 2008, Brain : a journal of neurology.

[5]  A. Dale,et al.  Whole Brain Segmentation Automated Labeling of Neuroanatomical Structures in the Human Brain , 2002, Neuron.

[6]  J. Lafferty,et al.  Sparse additive models , 2007, 0711.4555.

[7]  Jane S. Paulsen,et al.  A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length , 2004, Clinical genetics.

[8]  N. Georgiou-Karistianis,et al.  A peek inside the Huntington's brain: will functional imaging take us one step closer in solving the puzzle? , 2009, Experimental Neurology.

[9]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[10]  Jane S. Paulsen,et al.  White Matter Volume and Cognitive Dysfunction in Early Huntington's Disease , 2005, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

[11]  Jane S. Paulsen,et al.  fMRI detection of early neural dysfunction in preclinical Huntington's disease , 2007, Journal of the International Neuropsychological Society.

[12]  Marian DiFiglia,et al.  Huntington Disease , 1998, Journal of neuropathology and experimental neurology.

[13]  Russell A. Poldrack,et al.  Long-term test–retest reliability of functional MRI in a classification learning task , 2006, NeuroImage.

[14]  J. Brandt,et al.  Onset and rate of striatal atrophy in preclinical Huntington disease , 2004, Neurology.

[15]  C D Good,et al.  The distribution of structural neuropathology in pre-clinical Huntington's disease. , 2002, Brain : a journal of neurology.

[16]  G. Pearlson,et al.  Basal ganglia volume and proximity to onset in presymptomatic Huntington disease. , 1996, Archives of neurology.

[17]  Jennifer A. Mangels,et al.  A Neostriatal Habit Learning System in Humans , 1996, Science.

[18]  Daniel Ecker,et al.  Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI. , 2007, Brain : a journal of neurology.

[19]  Tom M. Mitchell,et al.  Machine learning classifiers and fMRI: A tutorial overview , 2009, NeuroImage.

[20]  Jane S. Paulsen,et al.  Brain Structure in Preclinical Huntington’s Disease , 2006, Biological Psychiatry.

[21]  X. Beristain,et al.  Specific psychiatric manifestations among preclinical Huntington disease mutation carriers. , 2007, Archives of neurology.

[22]  M. Gluck,et al.  Cortico-striatal contributions to feedback-based learning: converging data from neuroimaging and neuropsychology. , 2004, Brain : a journal of neurology.

[23]  Jane S. Paulsen,et al.  Automatic detection of preclinical neurodegeneration , 2009, Neurology.

[24]  Jane S. Paulsen,et al.  Psychiatric Symptoms in Huntington’s Disease before Diagnosis: The Predict-HD Study , 2007, Biological Psychiatry.

[25]  P. Matthews,et al.  Normalized Accurate Measurement of Longitudinal Brain Change , 2001, Journal of computer assisted tomography.

[26]  Jane S. Paulsen,et al.  Preparing for preventive clinical trials: the Predict-HD study. , 2006, Archives of neurology.

[27]  Jane S. Paulsen.  Functional imaging in Huntington's disease , 2009, Experimental Neurology.

[28]  Jane S. Paulsen,et al.  fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's Disease. , 2004, AJNR. American journal of neuroradiology.

[29]  G. Pearlson,et al.  Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.

[30]  Jane S. Paulsen,et al.  Obsessive and compulsive symptoms in prediagnosed Huntington's disease. , 2008, The Journal of clinical psychiatry.

[31]  H. Diana Rosas,et al.  Neuroprotection for Huntington’s disease: Ready, set, slow , 2008, Neurotherapeutics.

[32]  Sarah A. J. Reading,et al.  Regional white matter change in pre-symptomatic Huntington's disease: A diffusion tensor imaging study , 2005, Psychiatry Research: Neuroimaging.

[33]  I. Johnstone,et al.  Statistical challenges of high-dimensional data , 2009, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[34]  J. Ashburner,et al.  Progression of structural neuropathology in preclinical Huntington’s disease: a tensor based morphometry study , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[35]  Sarah A. J. Reading,et al.  Functional brain changes in presymptomatic Huntington's disease , 2004, Annals of neurology.

[36]  Stephen M. Smith,et al.  Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.

[37]  A. Aron,et al.  Contrasting gray and white matter changes in preclinical Huntington disease , 2010, Neurology.

[38]  Daniel Rueckert,et al.  Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data , 2006, NeuroImage.

[39]  E. Tolosa,et al.  Prefrontal cortex volume reduction on MRI in preclinical Huntington's disease relates to visuomotor performance and CAG number. , 2009, Parkinsonism & related disorders.

[40]  B Fischl,et al.  Regional cortical thinning in preclinical Huntington disease and its relationship to cognition , 2005, Neurology.

[41]  Jason Weston,et al.  Gene Selection for Cancer Classification using Support Vector Machines , 2002, Machine Learning.

[42]  G. Egan,et al.  Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease , 2008, Brain Research Reviews.